AeroLeads people directory · profile

Nick J. Manesis, Phd Email & Phone Number

Chief Technology Officer at PROPEDIX(TM) at ProPedix Inc
Location: San Diego, California, United States 12 work roles 8 schools
LinkedIn matched
✓ Verified May 2026 3 data sources Profile completeness 86%

Contact Signals

LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Chief Technology Officer at PROPEDIX(TM)
Location
San Diego, California, United States

Who is Nick J. Manesis, Phd? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Nick J. Manesis, Phd is listed as Chief Technology Officer at PROPEDIX(TM) at ProPedix Inc, based in San Diego, California, United States. AeroLeads shows a matched LinkedIn profile for Nick J. Manesis, Phd.

Nick J. Manesis, Phd previously worked as Chief Technology Officer at Propedix Inc and Principal Owner at Poragen Llc. Nick J. Manesis, Phd holds Doctor Of Philosophy - Phd, Chemistry from Uc San Diego.

Company email context

Email format at ProPedix Inc

This section adds company-level context without repeating Nick J. Manesis, Phd's masked contact details.

ProPedix Inc

Review company-level records connected to Nick J. Manesis, Phd before choosing the right outreach path.

Profile bio

About Nick J. Manesis, Phd

BACKGROUNDPharma, medical device, and combination product experience. Worked as Individual contributor in technical, quality, and regulatory functions. Managed U.S. and global teams. Built operations (R & D and scale-up manufacturing) departments. Supported quality, clinical studies, and regulatory submissions in both U.S. and EU. Product categories have included drug release, ophthalmology, medical aesthetics, reconstruction, wound healing, and inkjet printing. Built operations infrastructure involving staffing, lab and facility lay-out and build, and systems and procedures. Conducted product development activities in all size organizations, from early-stage to large cap. Enjoy building relationships with staff, KOL’s, and suppliers. Adept at critical thinking, strategic planning, and problem solving.EXPERIENCETechnical: CMC, medical device, combination product, biomaterials (synthetic and biological), , fabrication, delivery devices, analytical testing (chemical, physical, biological), animal studies, ISO 10993 biocompatibility.Corporate: Budget & finance, business development, team leadership & management, domestic & international teams, in-licensing, out-licensing.Functional Activities: R & D, Operations, Pre-clinical, biocompatibility ISO 10993, scale-up, manufacturing, supply chain, quality, project management, IP, clinical support, troubleshooting, FDA & EU MDR registration.Product Categories: Drug release, wound healing, ophthalmic implants, eye drops, spinal injectable, contact lenses, tissue integration, medical aesthetics (dermal fillers, breast implants), bariatric, packaging, inkjet.EDUCATIONPh.D., Chemistry | University of California – San DiegoB.S. degrees in Chemistry and Biology | U. of Wisconsin - Eau Claire

Current workplace

Nick J. Manesis, Phd's current company

Company context helps verify the profile and gives searchers a useful next step.

ProPedix Inc
Propedix Inc
Chief Technology Officer at PROPEDIX(TM)
AeroLeads page
12 roles

Nick J. Manesis, Phd work experience

A career timeline built from the work history available for this profile.

Chief Technology Officer

Current

Product development.

May 2024 - Present

Principal Owner

Current
  • PRODUCT AREA: Custom silicone formulations.INDUSTRY: Biomedical device | multiple healthcare areas (wound healing, medical aesthetics, tissue scaffolding, cell culture).KEYWORDS: Open-cell silicone foam | wettable |.
  • Founded early-stage business engaged in building out technology platform based on open-cell porous structures for healthcare applications.
  • Licensing Agreement finalized with healthcare company per specific fields of use.
  • Lead inventor on composition, process of manufacture, and method-of-use PCT patent applications.
  • Strong IP position covering composition-of-matter, method-of-manufacture, and method-of-use applications. U.S. and PCT applications filed.
  • Developed composition and method-of-manufacture.
Mar 2013 - Present

Chief Scientific Officer

Spineovations, Inc. | 33 Medical, Inc.
  • PRODUCT AREA: Spinal injection for relief of lower back pain.INDUSTRY: Medical device | orthopedics (spine).RESPONSIBILITIES & ACCOMPLISHMENTS:
  • Active member of cross-functional international team responsible for key elements within R & D, manufacturing, clinical research, regulatory affairs, intellectual property, and investor outreach.
  • Managed pre-clinical activities including product development, scale-up manufacturing, animal studies, ISO 10993 biocompatibility tests. Generated documentation for design control, DHF, Design Dossier, and technical.
  • Managed safety and performance activities. Developed R & D strategy involving biomaterial formulation, characterization and bio-simulation testing. Managed animal study protocol, explantation, and histopathology..
  • Developed injection composition based on hyaluronic acid (HA) and acrylic microspheres. Optimized material for extrusion through 22 G needle. Set biological, chemical, and physical specs for incoming raw material and.
  • Managed supply chain. Conducting sourcing and qualification of raw materials. Managed finished product activities within contract manufacturer.
Feb 2015 - Apr 2024

Vice President, Operations/Research & Development

Revision Optics / Optics Medical
  • PRODUCT AREA: Corneal implant for treatment of presbyopia, pharma eye drops for presbyopia.INDUSTRY: Medical device | pharmaceutical | ophthalmic.STAFF: 6 employees, 4 consultants.BUDGET(ANNUAL): $2.5M.
  • Managed interdisciplinary team: design & mechanical engineers, material & analytical scientists, medical affairs, clinicians, practitioners, and optical engineering.
  • Developed fully biocompatible corneal implant without use of steroid anti-inflammatories. 3-Year animal implants no inflammation with no degradation.
  • Managed in-licensing of pilocarpine-based formulation for presbyopia. Conducted formulation vs efficacy studies. Responsible for CMC activities.
  • Engaged in technical marketing, IP portfolio, and regulatory support. Interfaced with KOL’s, practitioners, and academicians.
  • Built Operations infrastructure from scratch. Areas included: lab and clean room design & build-out, materials development, fabrication, scale-up and manufacturing lines, QC, and clinical supplies.
Aug 2016 - Apr 2021

Vice President, Research & Development

Dublin, Coolock, IE

  • PRODUCT AREA: Dermal filler, breast implants, tissue expander, gastric.INDUSTRY: Medical device | combination products | medical aesthetics.STAFF: 24 employees U.S., 28 employees international.BUDGET(ANNUAL): $15M.
  • Provided leadership & management of U.S. and international functional teams totaling 52 persons.
  • Created Materials Development & Analytical Services functions from the ground up. Created infrastructure including staffing, lab build-out, and systems & procedures. Capabilities were showcased throughout entire pharma.
  • Delivered performance-oriented product attributes by effectively integrating material science, engineering, and analytical activities in the development of medical aesthetics products.
  • Managed yearly budgets up to $15M USD with targeted variance less than 3% quarter-to-quarter.
  • Spearheaded knowledge transfer, expertise, and analytical capabilities across multiple departments within both device and pharma communities.
Jul 2008 - Jun 2013

Director, Chemistry & Materials Science

San Ramon, California, US

  • PRODUCT AREA: Contact lens.INDUSTRY: Medical device. Ophthalmics.STAFF: 25 employees U.S.BUDGET(ANNUAL): $6M USD.RESPONSIBILITIES & ACCOMPLISHMENTS:
  • Developed strategy and managed material development activities for multiple projects: daily-wear Avaira™ silicone lens product, low- cost silicone daily disposable product, cost reduction of the existing Biofinity™.
  • Responsible for establishing Materials Development and Analytical Testing infrastructure. Interfaced with manufacturing and QA to ensure proper technology transfer and design control documentation.
  • Instrumental in developing and implementing strategy for developing the first silicone hydrogel contact lens product on CooperVision’s existing manufacturing platform. Interfaced with chemical suppliers targeting.
  • Managed internal staff of 25 scientists and process engineers and supported international teams of up to 30 persons within UK and Puerto Rico R & D, Quality, and Manufacturing areas.
Mar 2004 - Jun 2008

Director, Business Development

Smart Products

PRODUCT AREA: Preservative-free packaging, eye drops.INDUSTRY: Packaging, ophthalmic

Jun 2000 - Mar 2004

Engineer

Hp

Palo Alto, CA, US

PRODUCT AREAS: Inkjet media products, small & large format.INDUSTRY: Electronic printing.

Jul 1994 - Jun 2000

Sr. Scientist

Pilkington Barnes Hind

PRODUCT AREAS: Contact lens.INDUSTRY: Medical device. Ophthalmic

Jan 1989 - May 1994

Sr. Scientist

Allergan Medical Optics

PRODUCT AREAS: Corneal implant, epikeratophakia.INDUSTRY: Medical device. Ophthalmic.

Sep 1987 - Jan 1989

Grad Student

La Jolla, CA, US

Thesis title: "Synthesis and Conformational Analysis of beta-Turns as Model Systems for Proteins." Advisor: Dr. Murray Goodman.

Aug 1981 - Jun 1986

R & D Technician

Albuquerque, NM, US

Supported research programs in the areas of solar energy and combustion.

Jun 1980 - Aug 1981
8 education records

Nick J. Manesis, Phd education

Doctor Of Philosophy - Phd, Chemistry

Uc San Diego

Ph. D., Chemistry

Uc San Diego

Doctor Of Philosophy - Phd, Chemistry

Uc San Diego

M.S., Chemistry

Uc San Diego

B.S., Chemistry

University Of Wisconsin-Eau Claire

B.S., Biology

University Of Wisconsin-Eau Claire

Doctor Of Philosophy - Phd, Chemistry

Uc San Diego

Doctor Of Philosophy - Phd, Chemistry

Uc San Diego
FAQ

Frequently asked questions about Nick J. Manesis, Phd

Quick answers generated from the profile data available on this page.

What company does Nick J. Manesis, Phd work for?

Nick J. Manesis, Phd works for ProPedix Inc.

What is Nick J. Manesis, Phd's role at ProPedix Inc?

Nick J. Manesis, Phd is listed as Chief Technology Officer at PROPEDIX(TM) at ProPedix Inc.

Where is Nick J. Manesis, Phd based?

Nick J. Manesis, Phd is based in San Diego, California, United States while working with ProPedix Inc.

What companies has Nick J. Manesis, Phd worked for?

Nick J. Manesis, Phd has worked for Propedix Inc, Poragen Llc, Spineovations, Inc. | 33 Medical, Inc., Revision Optics / Optics Medical, and Allergan, Inc..

How can I contact Nick J. Manesis, Phd?

You can use AeroLeads to view verified contact signals for Nick J. Manesis, Phd at ProPedix Inc, including work email, phone, and LinkedIn data when available.

What schools did Nick J. Manesis, Phd attend?

Nick J. Manesis, Phd holds Doctor Of Philosophy - Phd, Chemistry from Uc San Diego.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.